FROM Kevin Davies
Genome Companies Dominate the Southland Last week, we talked about the development of genome sequencing , which took 10 years and $2 billion twenty years ago. Since then, it’s developed at an astonishing pace, centered in Southern California. Kevin Davies is editor-in-chief of Bio-IT World and author of The $1000 Genome : The Revolution in DNA Sequencing and the New Era of Personalized Medicine.
The $1,000 Genome and 'Personalized Medicine' It took $2 billion and ten years to complete the Human Genome Project . Now, just ten years later, many individuals have had their genomes sequenced, and the cost keeps dropping. Kevin Davies is editor of Bio-IT World , which covers the role of technology in the life sciences. He's also the author of The $1000 Genome : The Revolution in DNA Sequencing and the New Era of Personalized Medicine.
Venezuela spirals into economic and political chaos Venezuela, a country whose potential for prosperity is unmatched, finds itself on the verge of civil war. What sustains the repressive government? With time running out, guest host León Krauze looks at what the international community can do to pull the country from the edge of collapse.
The Trump agenda: where's the beef? President Trump says big things are happening. After celebrating a House bill on health care, he doesn’t yet have Senate agreement. With James Comey’s public testimony scheduled tomorrow, the President today tweeted his selection of a new FBI Director. Is the Chief Executive all style and no substance? Later, terror attacks in Iran and conflicting claims about who’s behind them.
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.
Will the Senate write a healthcare bill in secret? While Democrats and Republicans argue White House relations with Russia, another question is being decided behind closed doors: who gets help buying health insurance and who doesn't? We hear how the pros and cons are being shrouded in secrecy.